Navigation Links
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
Date:8/27/2007

y anti-apoptotic proteins such as XIAP. Loss of activity of these proteins restores the ability of chemoresistant tumour cells to undergo apoptosis in response to chemotherapy. The putative molecular target for phenoxodiol is a tumour-specific protein, accounting for the highly selective nature of the drug.

About Marshall Edwards, Inc.: Marshall Edwards, Inc. (Nasdaq: MSHL) is a specialist oncology company focused on the clinical development of novel anti- cancer therapeutics. These derive from a flavonoid technology platform which has generated a number of novel compounds characterised by broad ranging efficacy against a range of cancer targets with few side effects. The unique combination of efficacy and safety has been explained by their ability to target an enzyme present on the surface of cancer cells, thereby inhibiting the production of pro-survival proteins within the cell. Marshall Edwards, Inc., has licensed rights from Novogen Limited (ASX: Novogen - Nasdaq: NVGN) to bring three oncology drugs - phenoxodiol, NV-196 and NV-143 - to market globally. Marshall Edwards, Inc., is majority owned by Novogen, an Australian biotechnology company that is specialising in the development of therapeutics based on a flavonoid technology platform. Novogen, based in Sydney, Australia, is developing a range of therapeutics across the fields of oncology, cardiovascular disease and inflammatory diseases. More information on phenoxodiol and on the Novogen group of companies can be found at and http://www.novogen.com .

(1) Piura B and Meirovitz M. Weekly single-agent carboplatin in heavily

pretreated patients with recurrent ovarian, peritoneal and fallopian


'/>"/>

SOURCE Novogen Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: Global Coatings ... http://www.reportlinker.com/p01375204/Global-Coatings-for-Medical-Devices-Industry.html This report analyzes ... in US$ Million by the following Product Segments: ... Coatings. The report provides separate comprehensive analytics for ...
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... Aug. 20, 2014  Glades Drugs, an independent pharmacy chain ... to announce its expansion into a new corporate headquarters in ... an 8,000-square-foot office space and state of the art lab. ... 100 open positions for the new facility. ... will serve as the chain,s corporate headquarters and closed door ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... , Jan. 20 Ethicon, Inc., announced ... Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. ... to designing, developing and commercializing devices that address conditions ... announced its agreement to acquire Acclarent on December ...
... Jan. 20 Medical device maker Smith & Nephew,s (NYSE: ... week more than $2 million in implants and surgical instruments ... week,s earthquake in Haiti . , The donation, set to arrive ... treat bone fractures. , These resources are being distributed in ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments 2Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments 3
(Date:8/21/2014)... OpsAssure, the local start-up offering software-as-a-service, ... in the Harbor Accelerator's 14 week development program. ... valuable resources.he Harbor’s goal is to launch innovative ... selected for the program receives a variety of ... grow quickly, test markets and become viable in ...
(Date:8/21/2014)... NY (PRWEB) August 21, 2014 Recently nominated as ... been on quite the journey to be the man he is ... and has always had a positive look on women, respecting them ... top, KC owes gratefulness and thanks to a man who he ... of years, Howard Stern. , KC Armstrong’s name will ring a ...
(Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous bamboo ... range of hand scraped bamboo floorings to ... Autumn special offer for these elegant items. According to ... discounted price, up to 25% off; the promotion will ... Providing natural looks and available in different varieties, the ...
(Date:8/20/2014)... (PRWEB) August 21, 2014 Top ... many web hosting companies and announced Bluehost ( ... recommended hosting companies that provide high quality PHP ... by Top 10 Best SEO Hosting are unbiased ... receive the best information possible. During the recent ...
(Date:8/20/2014)... 2014 On September 7th, 2014 Peoria will ... connects people living with MS with people who care. This ... are 85% of the way to their goal. This years ... at 11:30 and the walk starts at 1:00 pm. ... answer question about chiropractic care and how it helps symptoms ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2
... has received two grants totaling more than $4.3 million ... neuroscience and pediatric pharmacology and vision research as part ... four academic health centers and the College of Optometry. ... at SUNY Downstate Medical Center in Brooklyn, New York. ...
... (QUT ) School of Nursing and Midwifery, in Brisbane, ... in self-managing their health and emotional concerns. Participants ... for ongoing information and emotional support, compared to those ... "There are a range of post-treatment effects people might ...
... On April 8, 1982, alone in a laboratory, chemist ... an impossible pattern. He had discovered quasicrystals. But ... scientific establishment for years. On October 5, ... What compelled Shechtman to stand by his research? What ...
... -- ,Black and Hispanic children in the United States are ... after they suffer a minor head injury, a new study ... with head injuries treated at 25 pediatric emergency care trauma ... cranial CT scan. There were no significant race/ethnicity-related differences ...
... , FRIDAY, Oct. 14 (HealthDay News) -- One in ... that can spread E. coli, likely because so many people ... new study contends. The findings also suggest that many ... at the London School of Hygiene & Tropical Medicine and ...
... HealthDay Reporter , THURSDAY, Oct. 13 (HealthDay News) -- ... heart disease, continues to fall, according to new research from ... 6 percent of adults had heart disease in 2010, down ... pressure and high cholesterol, as well as declines in smoking, ...
Cached Medicine News:Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 2Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 3Health News:Nurses boost well-being for cancer survivors 2Health News:How and why did 2011 Nobel winner Dan Shechtman persist despite rejection? 2Health News:1 in 6 Cellphones in Britain Contaminated With 'Fecal Matter' 2Health News:U.S. Heart Disease Rates Keep Falling: CDC 2Health News:U.S. Heart Disease Rates Keep Falling: CDC 3
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Medicine Products: